Hutch News

Hutch News

Stories tagged 'Clinical Research'

Good News at Fred Hutch

Celebrating faculty and staff achievements

Nov. 30, 2017

The Parker Institute for Cancer Immunotherapy announced that Dr. Phil Greenberg, head of the Program in Immunology at the Hutch, has joined its team of more than 300 scientists from the academic, nonprofit, biotech and pharma sectors.

View story >


Adam Geballe elected AAAS Fellow

Hutch virologist honored for revealing key players in molecular ‘arms race’ between viruses and hosts

Nov. 20, 2017 | By Sabrina Richards / Fred Hutch News Service

Dr. Adam Geballe elected AAAS Fellow for pinpointing key players in molecular 'arms race' between viruses and human hosts

View story >


Targeted therapies push metastatic prostate cancer in new directions

Combination therapy could help stave off new “escape variant” of disease that arises in response to powerful treatments

Nov. 14, 2017 | By Sabrina Richards / Fred Hutch News Service

Dr. Pete Nelson and colleagues found that as hormone-targeting treatments grow more potent, recurrent prostate tumors are more often finding a new way around the drugs.

View story >


Scientists-turned-entrepreneurs share lessons learned launching startups

From venture capital to office space to acquisitions, academics starting companies face a steep learning curve — but there’s help to be found

Nov. 13, 2017 | By Rachel Tompa / Fred Hutch News Service

Scientists who make the leap from academia to founding their own companies face a steep learning curve. There's a lot to learn and a lot to take in. But help is available.

View story >


A new option for high-risk multiple myeloma?

Study of three-step treatment approach reopens question of donor bone marrow transplant

Nov. 9, 2017 | by Susan Keown / Fred Hutch News Service

A new study offers a clue for solving a long-standing controversy in multiple myeloma: namely, whether a bone marrow transplant from a donor could be beneficial for patients with this disease and, if so, for which patients.

View story >


First systematic study of infections after CAR T-cell therapy

“Benchmark” research could help reduce complications of emerging immunotherapy

Nov. 6, 2017 | by Susan Keown / Fred Hutch News Service

The first detailed study of infections after CAR T-cell therapy could help researchers improve the safety of this emerging type of genetically engineered cell therapy for cancer.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.